Ci Private Wealth, LLC Viking Therapeutics, Inc. Transaction History
Ci Private Wealth, LLC
- $56.4 Billion
- Q2 2024
A detailed history of Ci Private Wealth, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 12,329 shares of VKTX stock, worth $759,836. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,329
Previous 22,300
44.71%
Holding current value
$759,836
Previous $1.83 Million
64.28%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$371 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$316 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$139 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$115 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.73B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...